Predicting lung dosimetry of inhaled particleborne benzo[a]pyrene using physiologically based pharmacokinetic modeling

References

• ACD Labs. (2015). Advanced Chemistry Development Labs. [Online] Available from: http://www.acdlabs.com/.
   Google Scholar
• Anjivel A, Asgharian B. (1995). A multiple-path model of particle deposition in the rat lung. Fund Appl Toxicol 28:41–50.
   PubMedGoogle Scholar
• Barter ZE, Bayliss MK, Beaune PH, et al. (2007). Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab 8:33–45.
   PubMed Web of Science ®Google Scholar
• Brown RP, Delp MD, Lindstedt SL, et al. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–84.
   PubMed Web of Science ®Google Scholar
• Buckley TJ, Lioy PJ. (1992). An examination of the time course from human dietary exposure to polycyclic aromatic hydrocarbons to urinary elimination of 1-hydroxypyrene. Br J Ind Med 49:113–24.
   PubMedGoogle Scholar
• Chan BSH, Seale JP, Duggin GG. (1997). The mechanism of excretion of paraquat in rats. Toxicol Lett 90:1–9.
   PubMed Web of Science ®Google Scholar
• Chen YH, Xia EQ, Xu XR, et al. (2012). Evaluation of benzo[a]pyrene in food from China by high-performance liquid chromatography-fluorescence detection. Int J Environ Res Public Health 9:4159–69.
   PubMed Web of Science ®Google Scholar
• Chiang KC, Liao CM. (2006). Heavy incense burning in temples promotes exposure risk from airborne PMs and carcinogenic PAHs. Sci Total Environ 372:64–75.
   PubMed Web of Science ®Google Scholar
• Crowell SR, Amin SG, Anderson KA, et al. (2011). Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def, p]chrysene in rodents. Toxicol Appl Pharmacol 257:365–76.
   PubMed Web of Science ®Google Scholar
• Crowell SR, Hanson-Drury S, Williams DE, Corley RA. (2014). In vitro metabolism of benzo[a]pyrene and dibenzo[def, p]chrysene in rodent and human hepatic microsomes. Toxicol Lett 228:48–55.
   PubMed Web of Science ®Google Scholar
• Deziel NC, Strickland PT, Platz EA, et al. (2011). Comparison of standard methods for assessing dietary intake of benzo[a]pyrene. Cancer Epidemiol Biomarkers Prev 20:962–70.
   PubMed Web of Science ®Google Scholar
• EFSA (2008). European Food Safety Authority. Scientific opinion of the panel on contaminants in the food chain. EFSA J 724:1–114.
   Google Scholar
• Ewing P, Blomgren B, Ryrfeldt A, Gerde P. (2006). Increasing exposure levels cause an abrupt change in the absorption and metabolism of acutely inhaled benzo(a)pyrene in the isolated, ventilated, and perfused lung of the rat. Toxicol Sci 91:332–40.
   PubMed Web of Science ®Google Scholar
• Gerde P, Muggenburg BA, Henderson RF. (1993). Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the Beagle dog III. Mechanisms of the dosimetry. Toxicol Appl Pharmacol 121:328–34.
   PubMed Web of Science ®Google Scholar
• Gerde P, Muggenburg BA, Lundborg M, et al. (2001). Respiratory epithelial penetration and clearance of particle-borne benzo[a]pyrene. Resp Res Health Effects Inst 101:1–40.
   Google Scholar
• Heredia-Ortiz R, Maître A, Barbeau D, et al. (2014). Use of physiologically-based pharmacokinetic modeling to simulate the profiles of 3-hydroxybenzo(a)pyrene in workers exposed to polycyclic aromatic hydrocarbons. PLoS One 9:e102570
   PubMedGoogle Scholar
• Hood DB, Nayyar T, Ramesh A, et al. (2000). Modulation in the developmental expression profile of sp1 subsequent to transplacental exposure of fetal rats to desorbed benzo[a]pyrene following maternal inhalation. Inhal Toxicol 12:511–35.
   PubMed Web of Science ®Google Scholar
• Houston JB, Galetin A. (2008). Methods for predicting in vivo pharmacokinetics using data from in vitro assays. Curr Drug Metab 9:940–51.
   PubMed Web of Science ®Google Scholar
• IARC. 2010. IARC monographs on the evaluation of carcinogenic risks to humans, Volume 93, carbon black, Titanium Dioxide, and Talk. Lyon, France.
   Google Scholar
• ICRP (The International Commission on Radiological Protection). (2001). Basic anatomical and physiological data for use in radiological protection: reference values. Valentine J (ed). ICRP Publication 89, Oxford, UK: Pergamon Press.
   Google Scholar
• ICRP. (2002). Basic anatomical and physiological data for use in radiological protection reference values. ICRP Publication 89. Ann. ICRP 32 (3–4).
   Google Scholar
• Lafontaine M, Gendre C, Delsaut P, Simon P. (2004). Urinary 3-hydroxybenzo[a]pyrene as a biomarker of exposure to polycyclic aromatic hydrocarbons: an approach for determining a biological limit value. Polycycl Aromat Comp 24:441–50.
   Web of Science ®Google Scholar
• Lafontaine M, Champmartin C, Simon P, et al. (2006). 3-Hydroxybenzo[a]pyrene in the urine of smokers and non-smokers. Toxicol Lett 162:181–5.
   PubMed Web of Science ®Google Scholar
• Lu H, Zhu L. (2007). Pollution patterns of polycyclic aromatic hydrocarbons in tobacco smoke. J. Hazard. Mater 139:193–8.
   PubMed Web of Science ®Google Scholar
• Mage DT, Allen RH, Gondy G, et al. (2004). Estimating pesticide dose from urinary pesticides concentration data by creatinine correction in the third national health and nutrition examination survey (NHANES-III). J Expo Anal Env Epidemiol 14:457–65.
   PubMedGoogle Scholar
• Mallon BJ, Harrison FL. (1984). Octanol-water partition coefficient of benzo(a)pyrene: Measurement, calculation, and environmental implications. Bull Environ Contam Toxicol 32:316–23.
   PubMed Web of Science ®Google Scholar
• Miguel AH, Friedlander SK. (1978). Distribution of benzo[a]pyrene and coronene with respect to particle size in Pasadena aerosols in the submicron range. Atmos Environ 12:2407–13.
   Web of Science ®Google Scholar
• Mitchell C. (1982). Distribution and retention of benzo(A)pyrene in rats after inhalation. Toxicol Lett 11:35–42.
   PubMed Web of Science ®Google Scholar
• Mitchell C. (1983). The metabolic fate of benzo[a]pyrene in rats after inhalation. Toxicology 28:65–73.
   PubMed Web of Science ®Google Scholar
• Moir D, Viau A, Chu I, et al. (1998). Pharmacokinetics of benzo[a]pyrene in the rat. J Toxicol Environ Health Part A 53:507–30.
   PubMed Web of Science ®Google Scholar
• Moldoveanu SC, Coleman W III, Wilkins JM. (2008). Determination of polycyclic aromatic hydrocarbons in exhaled cigarette smoke. Beitr Tabakforsch Int 23:85–97.
   Google Scholar
• Moreau M, Bouchard M. (2015). Comparison of the kinetics of various biomarkers of benzo[a]pyrene exposure following different routes of entry in rats. J Appl Toxicol 35:781–90.
   PubMed Web of Science ®Google Scholar
• Pankow J. (2001). A consideration of the role of gas/particle partitioning in the deposition of nicotine and other tobacco smoke compounds in the respiratory tract. Chem Res Toxicol 14:165–1481.
   PubMed Web of Science ®Google Scholar
• Poulin P, Krishnan K. (1995). An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. J Toxicol Environ Health 46:117–29.
   PubMed Web of Science ®Google Scholar
• Poulin P, Theil FP. (2000). A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci 89:16–35.
   PubMed Web of Science ®Google Scholar
• Prough RA, Sipal Z, Jakobsson SW. (1977). Metabolism of benzo(a)pyrene by human lung microsomal fractions. Life Sci 21:1629–35.
   PubMed Web of Science ®Google Scholar
• Ramesh A, Greenwood M, Inyang F, Hood DB. (2001). Toxicokinetics of inhaled benzo[a]pyrene: plasma and lung bioavailability. Inhal Toxicol 13:533–55.
   PubMed Web of Science ®Google Scholar
• Ramesh A, Hood DB, Inyang F, et al. (2002). Comparative metabolism, bioavailability, and toxicokinetics of benzo[a]pyrene in rats after acute oral, inhalation, and intravenous administration. Polycycl Aromat Comp 22:969–80.
   Web of Science ®Google Scholar
• Rietjens IM, Dormans JA, Rombout PJ, van Bree L. (1988). Qualitative and quantitative changes in cytochrome P-450-dependent xenobiotic metabolism in pulmonary microsomes and isolated Clara cell populations derived from ozone-exposed rats. J Toxicol Environ Health 24:515–31.
   PubMed Web of Science ®Google Scholar
• Roemer E, Schramke H, Weiler H, et al. (2012). Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F and 2R4F. Beitr Tabkforsch 25:316–35.
   Google Scholar
• Roth RA, Vinegar A. (1990). Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo[a]pyrene disposition. Pharmacol Therapeut 48:143–55.
   PubMed Web of Science ®Google Scholar
• Schlede E, Kuntzman R, Haber S, Conney AH. (1970). Effect of enzyme induction on the metabolism and tissue distribution of benzo(alpha)pyrene. Cancer Res 30:2893–7.
   PubMed Web of Science ®Google Scholar
• Shamoo DA, Johnson TR, Trim SC, et al. (1991). Activity patterns in a panel of outdoor workers exposed to oxidant pollution. J Expo Anal Environ Epidemiol 1:423–38.
   PubMedGoogle Scholar
• St. Charles FK, McAughey J, Shepperd CJ. (2013). Methodologies for the quantitative estimation of toxicant dose to cigarette smokers using physical, chemical and bioanalytical data. Inhal Toxicol 25:383–97.
   PubMed Web of Science ®Google Scholar
• Sun JD, Wolff RK, Kanapilly GM. (1982). Deposition, retention, and biological fate of inhaled Benzo[a]pyrene absorbed onto ultrafine particles and as a pure aerosol. Toxicol Appl Pharmacol 65:231–44.
   PubMed Web of Science ®Google Scholar
• Sun JD, Wolff RK, Kanapilly GM, McClellan R. (1984). Lung retention and metabolic fate of inhaled benzo(a)pyrene associated with diesel exhaust particles. Toxicol Appl Pharmacol 73:48–59.
   PubMed Web of Science ®Google Scholar
• Thyssen J, Althoff J, Kimmerle G, Mohr U. (1981). Inhalation studies with benzo[a]pyrene in Syrian golden hamsters. J Natl Cancer Inst 66:575–7.
   PubMed Web of Science ®Google Scholar
• USEPA. (1994). Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. US Environmental Protection Agency, Office of Health and Environmental Assessment. EPA/600/8-90/066F.
   Google Scholar
• USEPA. (2005). Guidelines for carcinogen risk assessment. US Environmental Protection Agency. EPA/630/P-03/001F.
   Google Scholar
• USEPA. (2013). Toxicological review of Benzo[a]pyrene (CASRN 50-32-8) in support of summary information on the integrated risk information system (IRIS) (Public comment draft). US Environmental Protection Agency, Office of Research and Development. EPA/635/R13/138a
   Google Scholar
• USEPA. (2011). Exposure factors handbook: 2011 edition. September. United States Environmental Protection Agency, Office of Research and Development, Washington, DC. EPA/600/P-95/002Fa.
   Google Scholar
• Wiersma DA, Roth RA. (1983). Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung. J Pharmacol Exp Ther 226:661–7.
   PubMed Web of Science ®Google Scholar
• Withey JR, Shelden J, Law FCP, Abedini S. (1993). Distribution of benzo[a]pyrene in pregnant rats following inhalation exposure and a comparison with similar data obtained with pyrene. J Appl Toxicol 13:193–202.
   PubMed Web of Science ®Google Scholar
• Wolff RK, Griffith WC, Henderson RF, et al. (1989). Effects of repeated inhalation exposures to 1-nitropyrene, benzo[a]pyrene, Ga2O3 particles, and SO2 alone and in combinations on particle clearance, bronchoalveolar lavage fluid composition, and histopathology. J Toxicol Env Health 27:123–38.
   PubMed Web of Science ®Google Scholar
• Xue W, Warshawsky D. (2005). Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206:73–93.
   PubMed Web of Science ®Google Scholar